QF
ABUS icon

QVT Financial’s Arbutus Biopharma ABUS Stock Holding History

QVT Financial’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-16,013,540
Closed -$80.9M – 54
2017
Q4 		$80.9M Hold
16,013,540
– – 4.56% 6
2017
Q3 		$99.3M Hold
16,013,540
– – 3.7% 6
2017
Q2 		$57.6M Hold
16,013,540
– – 1.54% 9
2017
Q1 		$52M Hold
16,013,540
– – 1.62% 9
2016
Q4 		$39.2M Hold
16,013,540
– – 1.19% 11
2016
Q3 		$55.1M Buy
+16,013,540
New +$62.6M 2.08% 8
2015
Q4 		– Sell
-16,013,540
Closed -$97.5M – 81
2015
Q3 		$97.5M Hold
16,013,540
– – 3.34% 5
2015
Q2 		$190M Hold
16,013,540
– – 2.87% 4
2015
Q1 		$280M Buy
+16,013,540
New +$328M 15.57% 2

Other funds holding ABUS

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

QVT Financial's ABUS Position: Q1 2018 in Review

QVT Financial sold out of Arbutus Biopharma (ABUS) in Q1 2018, closing a stake of 16,013,540 shares — an estimated $80.9M sold.

QVT Financial first reported a position in ABUS in Q1 2015 and held it in 9 quarters. The position peaked at $280M in Q1 2015. 50 funds tracked by Wall St. Rank hold ABUS as of Q1 2018.

  • QVT Financial reported no remaining Arbutus Biopharma position as of Q1 2018 after selling out during the quarter.
  • QVT Financial sold 16,013,540 Arbutus Biopharma shares in Q1 2018, an estimated $80.9M.
  • QVT Financial first reported a position in Arbutus Biopharma in Q1 2015 and held it in 9 quarters.
  • QVT Financial's Arbutus Biopharma position peaked at $280M in Q1 2015.
  • 50 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q1 2018.

Based on QVT Financial's 13F filing for Q1 2018, filed 15 May 2018.